CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis

Published:2015-04 Issue:2 Volume:35 Page:147-156
ISSN:1672-0733
Container-title:Journal of Huazhong University of Science and Technology [Medical Sciences]
language:en
Short-container-title:J. Huazhong Univ. Sci. Technol. [Med. Sci.]

Author:

Niu Xuan,Mao Ling,Huang Yan,Baral Suraj,Li Jian-yong,Gao Yuan,Xia Yuan-peng,He Quan-wei,Wang Meng-die,Li Man,Zou Li,Miao Xiao-ping,Hu Bo

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biomedical Engineering,Biomaterials,Biochemistry

Link

http://link.springer.com/content/pdf/10.1007/s11596-015-1404-7.pdf

Reference53 articles.

1. Snoep JD, Hovens MM, Eikenboom JC, et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J, 2007,154(2):221–231

2. Food U. Drug Administration. FDA Drug Safety Communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. FDA, 2010

3. Pare G, Mehta SR, Yusuf S, et al. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med, 2010,363(18):1704–1714

4. Wallentin L, James S, Storey RF, et al. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Lancet, 2010,376(9749):1320–1328

5. Liang ZY, Han YL, Zhang XL, et al. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. EuroIntervention, 2013,9(3):316–327

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach;International Journal of Cardiology;2024-11

2. Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis;Drugs;2024-09-05

3. The Association between CYP2C19 Genetic Polymorphism and Prognosis in Patients Receiving Endovascular Therapy;Annals of Indian Academy of Neurology;2024-01

4. Genogeografiya farmakogeneticheski znachimyh DNK-markerov CYP2C19 supersemejstva citohromov v narodonaselenii Rossii i sopredel'nyh stran;Вестник Российского государственного медицинского университета;2023-10

5. Gene geography of pharmacogenetically significant CYP2C19 cytochrome superfamily DNA markers in the populations of Russia and neighboring countries;Bulletin of Russian State Medical University;2023-10